Third Taiwan firm gets go-ahead for human COVID-19 vaccine trial
Radio Taiwan International
Date: 31 August, 2020
By: John Van Trieste
A third Taiwanese firm has received the go-ahead to begin human trials of a COVID-19 vaccine.
The Food and Drug Administration has given Medigen Vaccine Biologics Corp. permission to test a potential COVID-19 vaccine on humans. The company is the third Taiwanese firm to get permission to start phase one clinical trials so far.
Testing will take place on around 100 human volunteers over a two-month period, with results expected in November or December. Researchers will look at the vaccine’s effectiveness as well as any side effects it might have. [FULL STORY]